OWA
JAZZ icon

One Wealth Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

One Wealth Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$298K Sell
1,577
-661
-30% -$116K 0.04% 245
2025
Q4 		$380K Buy
2,238
+3
+0.1% +$460 0.05% 204
2025
Q3 		$295K Buy
+2,235
New +$268K 0.04% 237

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

One Wealth Advisors's JAZZ Position: Q1 2026 in Review

One Wealth Advisors reduced its Jazz Pharmaceuticals (JAZZ) stake by 30% in Q1 2026, selling an estimated $116K and leaving 1,577 shares worth $298K. The position accounts for 0.04% of the portfolio, ranked #245.

One Wealth Advisors first reported a position in JAZZ in Q3 2025 and has held it in 3 quarters since. The position peaked at $380K in Q4 2025. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • One Wealth Advisors held 1,577 shares of Jazz Pharmaceuticals worth $298K as of Q1 2026.
  • One Wealth Advisors sold 661 Jazz Pharmaceuticals shares in Q1 2026, an estimated $116K.
  • Jazz Pharmaceuticals made up 0.04% of One Wealth Advisors's portfolio in Q1 2026, its #245 holding.
  • One Wealth Advisors first reported a position in Jazz Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • One Wealth Advisors's Jazz Pharmaceuticals position peaked at $380K in Q4 2025.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on One Wealth Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.